197 related articles for article (PubMed ID: 24482900)
1. Interventions for restoring patency of occluded central venous catheter lumens (Review).
van Miert C; Hill R; Jones L
Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
[No Abstract] [Full Text] [Related]
2. Commentary on 'Interventions for restoring patency of central venous catheter lumens'.
Bauman ME; Massicotte MP
Evid Based Child Health; 2013 Mar; 8(2):750-1. PubMed ID: 23877888
[TBL] [Abstract][Full Text] [Related]
3. Hemodialysis tunneled-cuffed catheter-related atrial thrombus complicated with asymptomatic pulmonary emboli.
Zhang Z; Zhang D
J Vasc Access; 2018 Mar; 19(2):197-198. PubMed ID: 29147998
[No Abstract] [Full Text] [Related]
4. Restoring patency of occluded central venous catheters.
Hurtubise MR; Bottino JC; Lawson M; McCredie KB
Arch Surg; 1980 Feb; 115(2):212-3. PubMed ID: 7356837
[TBL] [Abstract][Full Text] [Related]
5. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
[TBL] [Abstract][Full Text] [Related]
6. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
7. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
Clase CM; Crowther MA; Ingram AJ; Cinà CS
J Thromb Thrombolysis; 2001 Apr; 11(2):127-36. PubMed ID: 11406727
[TBL] [Abstract][Full Text] [Related]
8. Is the removal of a central venous catheter always necessary in the context of catheter-related right atrial thrombosis?
Rossi L; Libutti P; Casucci F; Lisi P; Teutonico A; Basile C; Lomonte C
J Vasc Access; 2019 Jan; 20(1):98-101. PubMed ID: 29749281
[TBL] [Abstract][Full Text] [Related]
9. Interventions for restoring patency of occluded central venous catheter lumens.
van Miert C; Hill R; Jones L
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007119. PubMed ID: 22513946
[TBL] [Abstract][Full Text] [Related]
10. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
[TBL] [Abstract][Full Text] [Related]
11. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
12. [Treatment of obstruction and thrombosis due to central venous catheterization].
Leititis JU
Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
[TBL] [Abstract][Full Text] [Related]
13. The urokinase lock-therapy for hemodialysis occluded central venous catheters.
Li Cavoli G; Schillaci O; Zagarrigo C; Servillo F; Li Cavoli TV; Palmeri M; Rotolo U
Blood Purif; 2015; 39(1-3):238. PubMed ID: 25823425
[No Abstract] [Full Text] [Related]
14. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
Jacobs BR; Haygood M; Hingl J
J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
[TBL] [Abstract][Full Text] [Related]
15. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
16. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters (PASSPORT 1).
Kumwenda MJ; Mitra S; Khawaja A; Inston N; Nightingale P
J Vasc Access; 2019 Nov; 20(6):752-759. PubMed ID: 31466489
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
18. Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.
Wójtowicz D; Cholewa D; Faba AM; Domańska B; Kokoszka J; Kopacz K; Ficek R; Irzyniec T; Rotkegel SE; Chudek J
Ren Fail; 2018 Nov; 40(1):384-389. PubMed ID: 30010473
[TBL] [Abstract][Full Text] [Related]
19. The use of streptokinase for restoration of patency to hemodialysis central venous catheters: a low-cost, safe and effective option.
Bashardoust B; Habibzadeh S; Sharghi A; Eskandari R; Maleki N
J Vasc Access; 2017 Sep; 18(5):e70. PubMed ID: 28777422
[No Abstract] [Full Text] [Related]
20. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
